94 - Oral Semaglutide vs Placebo in Patients With Type 2 Diabetes and Moderate Renal Impairment: PIONEER 5

التفاصيل البيبلوغرافية
العنوان: 94 - Oral Semaglutide vs Placebo in Patients With Type 2 Diabetes and Moderate Renal Impairment: PIONEER 5
المؤلفون: Signe Rosenlund, Thozhukat Sathyapalan, Thalia Marie Blicher, Simon Heller, Ofri Mosenzon, Robyn L. Houlden, Richard E. Pratley, Ole Holm Hels, Jan W. Eriksson, Cyrus Desouza
المصدر: Canadian Journal of Diabetes. 43:S35-S36
بيانات النشر: Elsevier BV, 2019.
سنة النشر: 2019
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Endocrinology, Diabetes and Metabolism, Semaglutide, General Medicine, Type 2 diabetes, medicine.disease, Placebo, Endocrinology, Internal medicine, Internal Medicine, medicine, In patient, business
تدمد: 1499-2671
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::fd654afa5c8d1eacfff379f4d71b1e1bTest
https://doi.org/10.1016/j.jcjd.2019.07.103Test
حقوق: CLOSED
رقم الانضمام: edsair.doi...........fd654afa5c8d1eacfff379f4d71b1e1b
قاعدة البيانات: OpenAIRE